Systemic lupus erythematosus (SLE) may be more prevalent among most ethnic groups in
the low-and-middle income countries (LMICs), still these countries are under-represented in …

Introduction The FDA approved the anti-BAFF monoclonal antibody, belimumab, in 2011 for
adult systemic lupus erythematosus (SLE), in 2019 for pediatric SLE, in 2020 for adult lupus …

Abstract Background Coronavirus disease-2019 (COVID-19) is a novel infectious disease,
which presents with various clinical manifestations. There is growing evidence of an …

Background. Dysbiosis of gut microbiota could promote autoimmune disorders including
systemic lupus erythematosus (SLE). Clarifying this point would be of great importance in …

microRNA-146a (miR-146a) plays an essential role in immune anomalies and organ injury
of systemic lupus erythematosus (SLE) by regulating the disease's inflammation and …

Objectives To evaluate the musculoskeletal (MSK) symptoms experienced by SLE patients
and determine how those symptoms relate to their health-related quality of life (HRQoL) …

Objectives This study aims to present the manifestations of juvenile systemic lupus
erythematosus (JSLE) across Egypt, to focus on age at onset and gender-driven influence …

Aim of the work To investigate whether or not neutrophil-to-lymphocyte ratio (NLR) and
platelet-to-lymphocyte ratio (PLR) may by indicators of disease activity in systemic lupus …

Aim of the work To investigate the association of interleukin-37 (IL-37)(rs3811047)
polymorphism with lupus nephritis (LN) in systemic lupus erythematosus (SLE) patients …

Aim of the work To assess the impact of antiphospholipid syndrome (APS) on systemic lupus
erythematosus (SLE) clinical characteristics and disease outcome. Patients and methods …